| Literature DB >> 33860141 |
Tatsuro Yamaguchi1, Keiichi Takahashi1, Kazutaka Yamada2, Hiroyuki Bando3, Hideo Baba4, Masaaki Ito5, Kimihiko Funahashi6, Hideki Ueno7, Shin Fujita8, Seiji Hasegawa9, Yoshiharu Sakai10, Kenichi Sugihara11.
Abstract
AIM: Neuroendocrine tumors (NETs) are one of the subtypes of neuroendocrine neoplasms and are defined as epithelial neoplasms with predominant neuroendocrine differentiation. The aim of this study was to clarify the clinicopathological characteristics of colorectal NETs through a nationwide retrospective study in Japan.Entities:
Keywords: neuroendocrine neoplasms; neuroendocrine tumors; rectal tumors
Year: 2020 PMID: 33860141 PMCID: PMC8034696 DOI: 10.1002/ags3.12403
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
FIGURE 1The treatment outline of colorectal neuroendocrine neoplasms patients. Clinical diagnosis, treatment course, recurrence site and tumor grade were shown. After a total of 390 patients had undergone surgical resection, liver metastasis in five patients and local recurrence in three patients occurred. CTx, chemotherapy; ETx, endoscopic treatment; H−, negative of liver metastasis; H+, positive of liver metastasis; N−, negative of lymph node metastasis; N+, positive of lymph node metastasis; NET, neuroendocrine tumor; Sur., surgical resection
Clinicopathological characteristics of colorectal neuroendocrine tumors
| All | NET G1 | NET G2 |
| ||
|---|---|---|---|---|---|
| Age | 59.0 (17‐86) | 63.5 (38‐79) | .20 | ||
| Gender | Male:female | 238:152 (39.0%) | 213:145 (40.5%) | 25:7 (21.9%) | .039 |
| Location | Upper rectum or more oral side:lower rectum | 54:334 (86.1%) | 45:311 (87.4%) | 9:23 (71.9%) | .028 |
| Size (mm) | <10:10≤ | 300:89 (22.9%) | 288:70 (19.6%) | 12:19 (61.3%) | <.0001 |
| Depressed lesion | Negative:positive | 273:71 (20.6%) | 258:56 (17.8%) | 15:15 (50.0%) | .0002 |
| Liver metastasis | Negative:positive | 387:3 (0.8%) | 357:1 (0.3%) | 30:2 (6.3%) | .019 |
| Depth of invasion | pT1:pT2≤ | 365:16 (4.2%) | 341:9 (2.6%) | 24:7 (22.6%) | <.0001 |
| Lymph node metastasis | Negative:positive | 317:54 (14.6%) | 301:40 (11.7%) | 16:14 (46.7%) | <.0001 |
| Lymphatic infiltration | Negative:positive | 306:53 (14.8%) | 289:41 (12.4%) | 17:12 (41.4%) | .0002 |
| Venous infiltration | Negative:positive | 280:78 (21.8%) | 269:61 (18.5%) | 11:17 (60.7%) | <.0001 |
| Chromogranin A | Negative:positive | 82:218 (72.7%) | 75:197 (72.4%) | 7:21 (75.0%) | 1 |
| Synaptophysin | Negative:positive | 22:271 (92.5%) | 21:245 (92.1%) | 2:26 (92.9%) | 1 |
Abbreviations: G, grade; NET, neuroendocrine tumor.
Univariate and multivariate analysis of the risk factors associated with lymph node metastasis
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| pN0 | pN+ |
| Odds ratio |
| ||
| Age | 55.9 ± 13.7 | 58.3 ± 12.2 | .36 | |||
| Gender | Male:female | 190:127 (40.1%) | 36:18 (33.3%) | .37 | ||
| Location | Upper rectum or more oral side:lower rectum | 44:272 (86.1%) | 8:46 (85.2%) | .83 | ||
| Size (mm) | <10:10≤ | 266:51 (16.1%) | 23:31 (57.4%) | <.0001 | 0.54 (0.21‐1.43) | .22 |
| Depressed lesion | Negative:positive | 242:39 (13.9%) | 20:28 (58.3%) | <.0001 | 4.98 (1.97‐12.60) | .0007 |
| Tumor grade | G1:G2 | 301:16 (5.0%) | 40:14 (25.9%) | <.0001 | 0.60 (0.193‐1.89) | .38 |
| Liver metastasis | Negative:positive | 316:1 (0.3%) | 52:2 (3.7%) | .057 | ||
| Depth of invasion | pT1:pT2≤ | 303:9 (2.9%) | 48:6 (11.1%) | .014 | 0.77 (0.15‐4.09) | .76 |
| Lymphatic infiltration | Negative:positive | 265:28 (9.6%) | 28:24 (46.2%) | <.0001 | ||
| Venous infiltration | Negative:positive | 253:40 (13.7%) | 17:35 (67.3%) | <.0001 | ||
| Lymphovascular infiltration | Negative:positive | 235:58 (19.8%) | 42:10 (19.2%) | <.0001 | 15.1 (6.22‐36.90) | <.0001 |
Abbreviations: G, grade; pN0, negative lymph node metastasis; pN+, positive lymph node metastasis.
FIGURE 2Frequency of lymph node metastasis according to number of predictive factors. There was significant correlation between frequency of lymph node metastasis and number of predictive factors, including size (>10 mm), depth of invasion (muscular propria or greater), NET grade (NET G2), depressed lesion of the tumor, and lymphovascular infiltration
Clinicopathological characteristics of colorectal NET with/without liver metastasis
| Liver metastasis− | Liver metastasis+ | ||
|---|---|---|---|
| Age | 56.6 ± 13.4 | 44.3 ± 11.0 | |
| Gender | Male:female | 233:151 (39.3%) | 3:0 |
| Location | Upper rectum or more oral side:lower rectum | 53:329 (86.1%) | 0:3 |
| Size (mm) | <10:10≤ | 298:85 (22.2%) | 1:2 |
| Depressed lesion | Negative:positive | 270:68 (20.1%) | 1:2 |
| Tumor grade | G1:G2 | 356:28 (7.3%) | 1:2 |
| Lymph node metastasis | Negative:positive | 315:50 (13.7%) | 1:2 |
| Depth of invasion | pT1:pT2≤ | 361:14 (3.7%) | 2:1 |
| Lymphatic infiltration | Negative:positive | 304:50 (14.1%) | 0:2 |
| Venous infiltration | Negative:positive | 279:74 (21.0%) | 0:2 |
| Lymphovascular infiltration | Negative:positive | 254:100 (28.2%) | 0:2 |
Abbreviations: G, grade; NET, neuroendocrine tumor.